Iconovo Gets Positive FDA Verdict On Ellipta Substitution

ICOpre Inhaler Endorsed By Agency; Earliest Potential EU Launch Date Remains 2027

 
• By Adam Zamecnik
  
FDA website displayed on smartphone
The FDA had positive news for Iconovo • Source: Shutterstock

More from Generics

More from Products